Diabetes and mortality in patients with COVID-19: Are we missing the link?

STİCCHİ, A., CEREDA, A., TOSELLİ, M., ESPOSİTO, A., PALMİSANO, A., VİGNALE, D., NİCOLETTİ, V., LEONE, R., GNASSO, C., MONELLO, A., KHOKHAR, A. A., LARİCCHİA, A., BİAGİ, A., TURCHİO, P., PETRİNİ, M., GALLONE, G., COBELL, F. D., PONTİCEL, F. (2021). Diabetes and mortality in patients with COVID-19: Are we missing the link?. The Anatolian Journal of Cardiology, Cilt: 25 - Sayı: 6, 376–379. https://ajindex.com/articles/365669

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (1)

Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Biondi-Zoccai G, et al. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic. J Am Coll Cardiol 2020; 75: 2352-71. [Crossref] 2. Huang I, Lim MA, Pranata R. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia - A systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr 2020; 14: 395-403. [Crossref] 3. The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China, 2020. China CDC Weekly 2020; 2: 113-22. [Crossref] 4. Rubino F, Amiel SA, Zimmet P, Alberti G, Bornstein S, Eckel RH, et al. New-Onset Diabetes in Covid-19. N Engl J Med 2020; 383: 789-90. [Crossref] 5. Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, et al. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. J Infect 2020; 81: e16-25. [Crossref] 6. Tian W, Jiang W, Yao J, Nicholson CJ, Li RH, Sigurslid HH, et al. Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis. J Med Virol 2020; 92: 1875-83. [Crossref] 7. Tatti P, Tonolo G, Zanfardino A, Iafusco D. Letter to the Editor: CoVid-19 and type 1 diabetes: Every cloud has a silver lining. Searching the reason of a lower aggressiveness of the CoronaVirus disease in type 1 diabetes. Diabetes Res Clin Pract 2020: 108270. [Crossref] 8. Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis 2020; 94: 91-5. [Crossref] 9. Jain V, Yuan JM. Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis. Int J Public Health 2020; 65: 533-46. [Crossref]